6-K ·Filed Jun 16, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No tradeable signal. This filing is purely administrative with no impact on valuation, pipeline, or financial outlook. Monitor upcoming clinical catalysts or earnings for material events.
Final — all horizons settled through T+60d ⚠ clustered
GMAB ▲ +30.27% at T+60d
NEUTRAL call ✓ call won +30.27% · α vs SPY +29.28% · entry $24.74 → $32.23
T+1d
+2.63%
call +2.63% · α +3.88%
$25.39
settled 4mo ago
T+5d
+4.85%
call +4.85% · α +7.08%
$25.94
settled 3mo ago
T+20d
+16.13%
call +16.13% · α +15.93%
$28.73
settled 3mo ago
T+60d
+30.27%
call +30.27% · α +29.28%
$32.23
settled 21d ago
Price Chart
Loading chart...
Executive Summary
Genmab filed a 6-K reporting a de minimis capital increase of 185 shares (DKK 0.2 million proceeds) from employee warrant exercises, representing less than 0.001% of share capital. This is a routine administrative event with no material impact on the company's financials or operations.
Key Facts
- Capital increase of 185 shares at DKK 1,334.50 per share
- Proceeds of approximately DKK 0.2 million
- Represents less than 0.001% of Genmab's share capital
- Total share capital after increase: DKK 62,353,252 (62,353,252 shares)
Financial Impact
De minimis — DKK 0.2 million proceeds, negligible dilution
dilution
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (25 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000094 |
| Document: gmab_20260616x6k.htm | 0001434265-26-000094 |
| Document: 0001434265-26-000094-index-headers.html | 0001434265-26-000094 |
| Document: 0001434265-26-000094-index.html | 0001434265-26-000094 |
| Document: 0001434265-26-000094.txt | 0001434265-26-000094 |
13 reports for GMAB
75% Hit rate best @ T+60▲ +26.50%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 24d ago | 6-K | $33.53 $32.65 | ▼ −2.62% | ▼ −1.96% | $34.51 (+2.94%) |
Aug 12, 2026 7w ago | 6-K | $31.42 $34.11 | ▲ +8.56% | ▲ +9.01% | $34.51 (+9.85%) |
Aug 11, 2026 7w ago | 6-K | $30.85 $32.96 | ▲ +6.84% | ▲ +7.24% | $34.51 (+11.88%) |
Aug 6, 2026 8w ago | 6-K | $29.83 $31.34 | ▲ +5.06% | ▲ +3.85% | $34.51 (+15.71%) |
Jul 15, 2026 11w ago | 6-K | $29.08 $28.85 | ▼ −0.79% | ▲ +0.19% | $34.51 (+18.69%) |
Jun 29, 2026 13w ago | 6-K | $27.47 $28.01 | ▲ +1.97% | ▲ +1.36% | $34.51 (+25.65%) |
Jun 17, 2026 15w ago | 6-K | $25.39 $25.87 | ▲ +1.87% | ▲ +2.91% | $34.51 (+35.94%) |
Jun 16, 2026 15w ago | 6-K | $24.74 $25.94 | ▲ +4.85% | ▲ +7.08% | $34.51 (+39.51%) |
Jun 15, 2026 15w ago | 6-K | $24.58 $25.61 | ▲ +4.19% | ▲ +5.57% | $34.51 (+40.42%) |
Jun 15, 2026 15w ago | 6-K | $24.58 $25.61 | ▲ +4.19% | ▲ +5.57% | $34.51 (+40.42%) |
Showing 10 of 13
US Market Status
Market Open — Closes in 48m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access